
NYSEHealthcareMedical - Pharmaceuticals
最新データ
$46.965
−$0.605 · -1.27%
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
通常取引
$46.965
−$0.605 · -1.27%
日中の時刻はETです。市場データは遅延する場合があります。
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
日中レンジ
現在 $46.965
52週レンジ
現在 $46.965
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
83
大幅な割安
センチメント
52
まちまち
リスク
42
やや高いリスク
モメンタム
30
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
日中レンジ
現在 $46.965
52週レンジ
現在 $46.965
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 10.89億 USD | 11.38億 USD | 11.25億 USD | 11.28億 USD | 10.87億 USD |
| 売上原価 | 5.14億 USD | 5.03億 USD | 5.01億 USD | 5.02億 USD | 4.66億 USD |
| 粗利益 | 5.75億 USD | 6.34億 USD | 6.24億 USD | 6.25億 USD | 6.21億 USD |
| 販売・一般管理 | 2.65億 USD | 2.64億 USD | 2.59億 USD | 2.52億 USD | 2.65億 USD |
| 営業費用 | 2.65億 USD | 2.98億 USD | 2.82億 USD | 6.48億 USD | 2.91億 USD |
| 支払利息 | 4233.9万 USD | 4763.2万 USD | 6716万 USD | 6916.4万 USD | 6428.7万 USD |
| 減価償却費と償却費 | 3127.3万 USD | 3017.3万 USD | 3067.5万 USD | 3262.5万 USD | 3209.2万 USD |
| 営業利益 | 3.09億 USD | 3.37億 USD | 3.42億 USD | −2241.5万 USD | 3.3億 USD |
| 純利益 | 1.9億 USD | 2.15億 USD | 2.09億 USD | −8230.6万 USD | 2.05億 USD |
会社概要が更新されました 2026年10月8日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
iShares Core S&P Small-Cap ETFIJR1.35億0.13%1042.94億 USD0.06%$136.12-0.70%
Vanguard Morningstar Total Stock Market ETFVTI7846.7万0.00%2.3兆 USD0.03%$379.61-0.37%
iShares Russell 2000 ETFIWM5966.44万0.08%785.63億 USD0.19%$275.18-0.91%
Vanguard Morningstar Small-Cap ETFVB5635.89万0.03%1853億 USD0.03%$285.25-0.60%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV3856.11万0.14%266.88億 USD0.33%$37.735-0.16%
Vanguard Morningstar Small-Cap Value ETFVBR3584.28万0.05%682億 USD0.05%$231.35-0.36%
Vanguard Extended Market ETFVXF2847.02万0.03%954億 USD0.05%$231.55-0.83%
Dimensional - US Targeted Value ETFDFAT2047.72万0.07%300.02億 USD0.33%$66.945-0.20%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
Dimensional - US Targeted Value ETFDFATAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。